Table 1.
Patients characteristics at baseline (n = 46) n (%)
| Median (range)/frequency | |
| Age (yr) | 59 (42-81) |
| Male sex | 28 (61) |
| Etiology | |
| Alcoholic liver disease | 33 (72) |
| Viral hepatitis | 6 (13) |
| Other | 7 (15) |
| Comorbidity | |
| Hepatocellular carcinoma | 9 (20) |
| Diabetes | 10 (22) |
| Child-Pugh stage | |
| A | 6 (13) |
| B | 19 (41) |
| C | 21 (46) |
| Ascites | 31 (67) |
| Child-Pugh score | 9 (5-14) |
| MELD score | 15 (6-27) |
| Bilirubin (µmol/L) | 61.4 (4-429) |
| International normalized ratio | 1.4 (0.9-2.6) |
| Creatinine (µmol/L) | 114 (43-533) |
| CrP (mg/L) | 23.1 (2-112.4) |
| Albumin (g/L) | 28 (17-51) |
| Sodium (mmol/L) | 135 (125-144) |
| White blood cells (Gpt/L) | 6.3 (1.2-22.2) |
| Platelets (Gpt/L) | 135 (29-442) |
| Alanine aminotransferase (µmol/L*s) | 1.41 (0.33-20.86) |
| Aspartate aminotransferase (µmol/L*s) | 1.6 (0.4-8.8) |
| Medication | |
| Non-selective beta blockers | 19 (41) |
| Lactulose | 21 (46) |
| Proton pump inhibitors | 36 (78) |
| Terlipressin | 1 (2) |
| Acetylsalicylic acid | 5 (11) |
Median and range or frequency and percent are shown.